Press Releases
May 28, 2024
PreciseDx Announces Poster Presentation at The 2024 American Society of Clinical Oncology Annual Meeting
See More
May 28, 2024
PreciseDx Announces Poster Presentation at The 2024 American Society of Clinical Oncology Annual Meeting
See More
Press Releases
Apr 2, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
Apr 2, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
Posters & Abstracts
Mar 22, 2024
EBCC-14 Poster: Clinical validation of an artificial-intelligent (AI) enabled digital test using the patient's diagnostic breast biopsy to predict invasive breast cancer recurrence within 6-years.
See More
Mar 22, 2024
EBCC-14 Poster: Clinical validation of an artificial-intelligent (AI) enabled digital test using the patient's diagnostic breast biopsy to predict invasive breast cancer recurrence within 6-years.
See More
Press Releases
Mar 22, 2024
PreciseDx Presents New Research on Their AI-Enabled Digital Test at 14th Annual European Breast Conference
See More
Mar 22, 2024
PreciseDx Presents New Research on Their AI-Enabled Digital Test at 14th Annual European Breast Conference
See More
Publications
Feb 24, 2024
Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer
See More
Feb 24, 2024
Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer
See More
Media Coverage
Jan 17, 2024
How AI Can Advance Breast Cancer Detection and Treatment
See More
Jan 17, 2024
How AI Can Advance Breast Cancer Detection and Treatment
See More
Media Coverage
Nov 14, 2023
Digital Morphology Solution Predicts Breast Cancer Recurrence
See More
Nov 14, 2023
Digital Morphology Solution Predicts Breast Cancer Recurrence
See More
Press Releases
Nov 3, 2023
PreciseDx's "Analytical Validation of a Digital Breast Cancer Test Predicting Recurrence in Early-Stage Breast Cancer" Featured in Clinical Breast Cancer
See More
Nov 3, 2023
PreciseDx's "Analytical Validation of a Digital Breast Cancer Test Predicting Recurrence in Early-Stage Breast Cancer" Featured in Clinical Breast Cancer
See More
No results.
Contact us today to learn more about PreciseBreast.
